Gujarat-based drugmaker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state ...

The authors write "The Food, Drug and Cosmetic Law Section of the New York State Bar Association is delving into the changing ...

Actavis was a generics giant whose rise mirrors the huge growth of off-patent medicines, while Gilead has rocketed into pharma's top 20 biggest companies in 2014 thanks to ground and record ...

The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain ...

AUSTIN, TX / ACCESSWIRE / January 10, 2025 / Aspira Women's Health Inc. ('Aspira' or the 'Company') (Nasdaq:AWH), a bio-analytical based women's health company focused on the development of ...

For branded drugmakers, the development of a pharmaceutical product approved by the Food and Drug Administration (FDA) all ...

Auden Mckenzie paid off would-be competitors AMCo (now known as Advanz Pharma) and Waymade to stay out of the market, according to the authority, while Actavis UK continued paying off AMCo after ...

Whereas Teva Pharmaceutical had north of $35 billion in net debt following its acquisition of Actavis in 2016, it now has less than $15.7 billion in net debt on its balance sheet. With Teva's long ...

It's settled long-standing opioid litigation, and the company has reduced its net debt from north of $35 billion following the Actavis buyout in 2016 to roughly $15.7 billion, as of the end of ...

It's settled long-standing opioid litigation, and the company has reduced its net debt from north of $35 billion following the Actavis buyout ... invest $1,000 in Teva Pharmaceutical Industries ...